Volume 14, Number 4—April 2008
Research
Control Measures Used during Lymphogranuloma Venereum Outbreak, Europe
Aura Timen*†
, Marlies E.J.L. Hulscher‡, Dieuwke Vos*†, Marita J.W. van de Laar*§, Kevin A. Fenton¶, Jim E. Van Steenbergen*, Jos W.M. van der Meer‡, and Richard P.T.M. Grol‡
, Marlies E.J.L. Hulscher‡, Dieuwke Vos*†, Marita J.W. van de Laar*§, Kevin A. Fenton¶, Jim E. Van Steenbergen*, Jos W.M. van der Meer‡, and Richard P.T.M. Grol‡
Table 1
Control measures used by 18 European countries during an LGV outbreak*
| Category | All countries (n = 18) | Countries with cases (n = 11) |
|---|---|---|
| Initial alert and response | ||
| Alert and response issued | 11 | 9 |
| Enhanced surveillance | 8 | 7 |
| Voluntary reporting | 9 | 7 |
| Provisional guidelines | 9 | 7 |
| Information dissemination | 11 | 9 |
| Educational activities |
6 |
6 |
| Development of control measures | ||
| Outbreak management team (advisory team) | 5 | 5 |
| Initial risk assessment performed | 8 | 7 |
| Methods to collect evidence | ||
| Hand search literature | 11 | 9 |
| Search electronic databases | 10 | 7 |
| Search patient entry data | 7 | 6 |
| Search unpublished data | 4 | 4 |
| Methods to analyze evidence | ||
| Decision analysis | 5 | 3 |
| Meta-analysis | 0 | 0 |
| Nonsystematic review | 5 | 4 |
| Systematic review | 4 | 4 |
| Experience based | 8 | 7 |
| Methods to formulate measures | ||
| Subjective review | 8 | 6 |
| Informal expert consensus | 10 | 8 |
| Formal expert consensus | 4 | 4 |
| Evidence based | 0 | 0 |
| Procedure for updating key recommendations | 11 | 4 |
| National LGV guideline | 4 | 3 |
| Formal authorization process of the guideline |
2 |
2 |
| Content of control measures | ||
| Active case finding | 9 | 7 |
| Contact tracing | 7 | 6 |
| Partner notification | 5 | 4 |
| Screening risk group | 5 | 3 |
| Activities targeting risk groups | 10 | 8 |
| Alerting general public | 1 | 1 |
| Alerting general practitioners | 8 | 5 |
| Alerting STI clinics | 11 | 9 |
| Alerting public health physicians | 9 | 9 |
| Alerting microbiologists | 9 | 6 |
| Alerting hospitals | 5 | 3 |
| Alerting GUM and gastroenterologists | 8 | 6 |
| Alerting HIV specialists | 3 | 3 |
| LGV notifiable† | 5 | 4 |
| National case-register for LGV† | 9 | 7 |
*Data gathered through a survey. LGV, lymphogranuloma venereum; STI, sexually transmitted infection; GUM, genitourinary specialists.
†Data were missing for 3 countries for this category.
Page created: July 13, 2010
Page updated: July 13, 2010
Page reviewed: July 13, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.